Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Azam Safary, Hakimeh Moghaddas-Sani, Mostafa Akbarzadeh-Khiavi, Alireza Khabbazzi, Mohammad A. Rafi & Yadollah Omidi. (2021) Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses. Expert Opinion on Biological Therapy 21:9, pages 1181-1197.
Read now
Read now
Carmen Garnacho & Silvia Muro. (2017) ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement. Journal of Drug Targeting 25:9-10, pages 786-795.
Read now
Read now
Dolan Sondhi, Jonathan B Rosenberg, Benjamin G Van de Graaf, Stephen M Kaminsky & Ronald G Crystal. (2013) Advances in the treatment of neuronal ceroid lipofuscinosis. Expert Opinion on Orphan Drugs 1:12, pages 951-975.
Read now
Read now
Articles from other publishers (25)
Seii Ohka, Soon Hao Tan, Eri Ishiyama, Katsutoshi Ogasawara, Tomohito Hanasaka, Kinji Ishida, Kyoji Hagiwara, Chia-Chyi Liu, Pele Choi-Sing Chong, Ken-ichi Hanaki & Giampietro Schiavo. (2022) The uncoating of EV71 in mature late endosomes requires CD-M6PR. Biology Open 11:9.
Crossref
Crossref
Azam Safary, Mostafa Akbarzadeh, Jaleh Barar & Yadollah Omidi. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
389
426
.
Valeria Calvaresi, Line T. Truelsen, Sidsel B. Larsen, Nikolaj H. T. Petersen, Thomas Kirkegaard & Kasper D. Rand. (2021) Conformational dynamics of free and membrane-bound human Hsp70 in model cytosolic and endo-lysosomal environments. Communications Biology 4:1.
Crossref
Crossref
Brigitte T. A. van den Broek, Jaap van Doorn, Charlotte V. HegemanStefan Nierkens, Caroline A. Lindemans, Nanda Verhoeven-Duif, Jaap Jan Boelens & Peter M. van Hasselt. (2020) Hurdles in treating Hurler disease: potential routes to achieve a “real” cure. Blood Advances 4:12, pages 2837-2849.
Crossref
Crossref
Jaclyn Cadaoas, Gabrielle Boyle, Steven Jungles, Sean Cullen, Michel Vellard, Jeffrey H. Grubb, Agnieszka Jurecka, William Sly & Emil Kakkis. (2020) Vestronidase alfa: Recombinant human β-glucuronidase as an enzyme replacement therapy for MPS VII. Molecular Genetics and Metabolism 130:1, pages 65-76.
Crossref
Crossref
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, Robert Preti, Tudor I. Oprea & Marco Prunotto. (2019) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery 19:2, pages 93-111.
Crossref
Crossref
Shifaza Mohamed, Qi Qi He, Arti A. Singh & Vito Ferro. 2020.
71
117
.
M. López Rodríguez. (2018) Treatment in Fabry disease. Revista Clínica Española (English Edition) 218:9, pages 489-495.
Crossref
Crossref
M. López Rodríguez. (2018) Tratamiento en la enfermedad de Fabry. Revista Clínica Española 218:9, pages 489-495.
Crossref
Crossref
Cathrine K. Fog, Paola Zago, Erika Malini, Lukasz M. Solanko, Paolo Peruzzo, Claus Bornaes, Raffaella Magnoni, Arnela Mehmedbasic, Nikolaj H.T. Petersen, Bruno Bembi, Johannes F.M.G. Aerts, Andrea Dardis & Thomas Kirkegaard. (2018) The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase. eBioMedicine 38, pages 142-153.
Crossref
Crossref
Azam Safary, Mostafa Akbarzadeh Khiavi, Rahimeh Mousavi, Jaleh Barar & Mohammad A Rafi. (2018) Enzyme replacement therapies: what is the best option?. BioImpacts 8:3, pages 153-157.
Crossref
Crossref
Melani Solomon & Silvia Muro. (2017) Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives. Advanced Drug Delivery Reviews 118, pages 109-134.
Crossref
Crossref
Fedah E. Mohamed, Lihadh Al-Gazali, Fatma Al-Jasmi & Bassam R. Ali. (2017) Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises. Frontiers in Pharmacology 8.
Crossref
Crossref
Jae-Wan Jung, Nguyen-Xuan Huy, Hyo-Boon Kim, Nan-Sun Kim, Do Van Giap & Moon-Sik Yang. (2017) Production of recombinant human acid α-glucosidase with high-mannose glycans in gnt1 rice for the treatment of Pompe disease. Journal of Biotechnology 249, pages 42-50.
Crossref
Crossref
Chloe Christensen & Francis Choy. (2017) A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells. Diseases 5:1, pages 6.
Crossref
Crossref
Edwin J. Vazquez-Cintron, Phillip H. Beske, Luis Tenezaca, Bao Q. Tran, Jonathan M. Oyler, Elliot J. Glotfelty, Christopher A. Angeles, Aurelia Syngkon, Jean Mukherjee, Suzanne R. Kalb, Philip A. Band, Patrick M. McNutt, Charles B. Shoemaker & Konstantin Ichtchenko. (2017) Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery. Scientific Reports 7:1.
Crossref
Crossref
Marina I. Giannotti, Ibane Abasolo, Mireia Oliva, Fernanda Andrade, Natalia García-Aranda, Marta Melgarejo, Daniel Pulido, José L. Corchero, Yolanda Fernández, Antonio Villaverde, Miriam Royo, María F. García-Parajo, Fausto Sanz & Simó SchwartzJr.Jr.. (2016) Highly Versatile Polyelectrolyte Complexes for Improving the Enzyme Replacement Therapy of Lysosomal Storage Disorders. ACS Applied Materials & Interfaces 8:39, pages 25741-25752.
Crossref
Crossref
Thomas KirkegaardJames GrayDavid A. PriestmanKerri-Lee WallomJennifer AtkinsOle Dines OlsenAlexander KleinSvetlana DrndarskiNikolaj H. T. PetersenLinda IngemannDavid A. SmithLauren MorrisClaus BornæsSigne Humle JørgensenIan WilliamsAnders HinsbyChristoph ArenzDavid BegleyMarja JäätteläFrances M. Platt. (2016) Heat shock protein–based therapy as a potential candidate for treating the sphingolipidoses. Science Translational Medicine 8:355.
Crossref
Crossref
S.A. Syed Haneef & C. George Priya Doss. 2016. Personalized Medicine. Personalized Medicine
225
265
.
Maurizio Scarpa, Cinzia Bellettato & Christina Lampe. 2016. Drug Discovery and Evaluation: Pharmacological Assays. Drug Discovery and Evaluation: Pharmacological Assays
4053
4069
.
Jeff Rappaport, Rachel L. Manthe, Carmen Garnacho & Silvia Muro. (2015) Altered Clathrin-Independent Endocytosis in Type A Niemann-Pick Disease Cells and Rescue by ICAM-1-Targeted Enzyme Delivery. Molecular Pharmaceutics 12:5, pages 1366-1376.
Crossref
Crossref
L. Choi, J. Vernon, O. Kopach, M.S. Minett, K. Mills, P.T. Clayton, T. Meert & J.N. Wood. (2015) The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain. Neuroscience Letters 594, pages 163-168.
Crossref
Crossref
Saikat Santra & Uma Ramaswami. (2015) Lysosomal disorders. Paediatrics and Child Health 25:3, pages 123-132.
Crossref
Crossref
Maurizio Scarpa, Cinzia Bellettato & Christina Lampe. 2014. Drug Discovery and Evaluation: Pharmacological Assays. Drug Discovery and Evaluation: Pharmacological Assays
1
20
.
Linda Ingemann & Thomas Kirkegaard. (2014) Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities. Journal of Lipid Research 55:11, pages 2198-2210.
Crossref
Crossref